Tacrolimus With Mini-Methotrexate as Prophylaxis for Graft-Versus-Host Disease in Pediatric Patients After Allogeneic Peripheral Blood Stem Cell Transplant or Bone Marrow Transplant

    loading  Checking for direct PDF access through Ovid


Experience with tacrolimus in combination with mini-methotrexate to prevent graft-versus-host disease (GVHD) is limited in pediatric patients undergoing allogeneic blood or bone marrow transplants. We reviewed our use of this regimen in 24 pediatric patients who had 26 blood or marrow transplants. Acute GVHD occurred in 7 patients (4 unrelated donor transplants, 3 matched sibling transplants; 5 grade I to II, 1 grade III, and 1 not classifiable). One patient had extensive chronic GVHD (matched sibling transplant). In our experience, tacrolimus with mini-methotrexate has been well tolerated with minimal toxicity.

Related Topics

    loading  Loading Related Articles